throbber
Acta anaestli. Scandinav. 1965, Supplementum XVI, 55-69.
`
`A C O M P A R I S O N OF T H E H Y D R O C H L O R I D E
`A N D CARBON D I O X I D E SALTS OF
`L I D O C A I N E A N D P R I L O C A I N E I N E P I D U R A L
`ANALGESIA
`
`PHILIP R. BROMACE
`
`In epidural analgesia the quality and extent of blockade varies widely
`with different drugs, and the technique provides a useful means of comparing
`the efficiency of local anaesthetics in man, since the onset and spread of anal-
`gesia is slow, allowing plenty of time for observation and comparative measure-
`ments.
`TRUANT and BROMACE (unpublished data) have shown, both in vivo and
`in vitro, that the carbonic salts of local anaesthetics have a more powerful
`blocking action than the conventional hydrochloride salts in equivalent concen-
`tration.
`This paper presents the effects of the 2 yo and 3 yo hydrochloride salts of
`lidocaine and prilocaine (propitocaine), compared with their carbonated salts
`formed by combining the anaesthetic bases with carbonic acid.
`
`T H E O R Y OF C A R B O N A T E D L O C A L A N A E S T H E T I C
`S O L U T I O N S
`Hydrogen-ion concentration is one of the most important factors influencing
`uptake of local anaesthetic drugs (KRAIIL et al. 1940, ALBERT 1952), and the
`choice of pH is a compromise between the two conflicting interests of water
`solubility on the one hand and solubility in a lipoid medium on the other,
`since an injectable local anaesthetic must dissolve in both media before it
`can reach its site of action.
`Local anaesthetics penetrate the lipoid phase of cell membranes as the
`electrically indifferent undissociated base, but since the base is only poorly
`soluble in water it must be prepared as a water-soluble salt before it can be
`injected in an aqueous medium:
`The equation :
`
`ALL 2044
`PROLLENIUM V. ALLERGAN
`IPR2019-01505 et al.
`
`

`

`56
`
`PHILIP R. BROMAGE
`
`proceeds to the left in an acid pH when ionization is almost complete, and to
`the right in an alkaline medium when ionization is minimal (Fig. 1). Many
`local anaesthetic solutions are dispensed with a low pH in the region of 4.0,
`for purposes of stability and prolonged storage life, and these solutions must
`be buffered in the tissues before sufficient free base is liberated to effect blockade.
`The time taken to buffer these acid salts delays analgesic action, and so potency
`tends to vary inversely with the initial hydrogen ion concentration (LOFGREN
`1948).
`
`IONIZATION OF A BASE DETERMINED BY pH
`
`4
`
`3
`
`2
`
`1
`
`P K ~ - P H o
`
`-1
`
`-2
`
`-3
`
`-4
`
`0
`
`10
`
`20
`
`30
`
`70
`
`80
`
`90
`
`10
`
`'
`
`40
`50
`60
`% IONIZATION
`FIG. I.-Relationship between pH and degree of ionization of local anaesthetics. When
`P+l
`PI
`the pKa = pH of solution, the ratio - = 1.
`The most efficient compromise in this dilemma between aqueous and lipoid
`solubility will be one that promotes rapid conversion of a water-soluble acid
`salt to undissociated free base. Being an acid gas, carbon dioxide can be made
`to combine with local anaesthetic bases, under the right conditions of low
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`57
`
`temperature and high partial pressure, and the resultant compounds are water
`soluble.
`Solutions of local anaesthetics prepared in this way have two interesting
`features. First, the drug is present in a bicarbonate form, which is very rapidly
`converted to the undissociated base once the partial pressure of carbon dioxide
`falls to that of the tissue. Second, although the pH of the carbonated solution
`is practically the same as that of the equivalent hydrochloride solutions, the
`rapid diffusion of carbon dioxide across cell membranes causes a fall of intra-
`cellular pH in the immediate neighbourhood, and the resulting electro-
`chemical gradient favours a greater uptake of local anaesthetic base by the
`tissues (CALDWELL 1958, HALPERN and BINACHI 1959, KRAHL and CLOWES
`1938, KRAHL et al. 1940).
`Solutions of lidocaine and prilocaine base have been made available in
`sealed ampoules at a pC0, of 700 mm Hg. The concentrations of base in these
`solutions was 1.75% and 1.71 yo respectively, which is equivalent to the amount
`present in 2% solutions of the corresponding hydrochloride salts.
`
`E XPE R I MENTAL M E T H 0 DS
`Observations of the speed of onset and segmental spread of analgesia and
`intensity of motor blockade were made in 659 patients receiving epidural
`analgesia.
`
`Solutions
`1. 2 yo and 3 yo lidocaine and prilocaine hydrochloride with and without
`adrenaline. When adrenaline was employed it was added freshly to the solution
`immediately prior to injection to produce a concentration of 1 : 200,000. The
`pH of these solutions were checked in a Radiometer pH meter and varied only
`between 6.27 and 6.71.
`2. (a) 1.75% lidocaine C0,-base (at a pC0, of 700 mm Hg) with and
`without adrenaline 1 :200,000; (b) 1.71 yo prilocaine C0,-base with adrenaline
`1 :200,000. The pH of these solutions was 6.49-6.51, measured at 28°C before
`any appreciable evolution of CO,. After equilibration with CO, at 35.6 mm
`Hg the pH rises to 7.30.
`The solutions were administered in the distribution shown in Table 1.
`Uncomplicated surgical patients and volunteers were chosen for the main
`part of the investigation. Subjects with occlusive vascular disease were excluded
`from this series, since they have atypical responses to epidural blockade (BRo-
`MACE 1962a, b). A smaller series of patients receiving continuous epidural
`blockade for labour pains and vaginal delivery has been presented, in order
`to compare the total requirements of analgesic base from the hydrochloride
`and C0,-base solutions over a long period.
`
`

`

`58
`
`Solution
`
`I
`
`Surgical patients
`2 yo plain lidocaine HCI.. ..........
`2 yo lidocaine HCI + adrenaline.. ...
`3 yo plain lidocaine HCI.. ..........
`3 yo lidocaine HCI + adrenaline.. . . .
`2 yo plain prilocaine HCI .... <. ....
`2 Yo prilocaine HCI + adrenaline . . .
`3 yo plain prilocaine HCI ..........
`3 % prilocaine HCl + adrenaline . . .
`1.75 Yo lidocaine base.. ...............
`1.75 Yo lidocaine base + adrenaline. . . .
`1.71 yo prilocaine base + adrenaline. . .
`
`Obstetrical patients
`2 yo lidocaine HCI + adrenaline.. ...
`2 % prilocaine HCI + adrenaline . . .
`1.75 Yo lidocaine base + adrenaline.. ...
`1.71 % prilocaine base + adrenaline . . .
`
`PHILIP R. BROMACE
`TABLE 1.
`Distribution of analgesic solutions in a series of 659 patients receiving
`epidural blockade for surgical and obstetrical indications.
`
`I Mean Age
`
`49.1
`48.6
`53.0
`47.0
`48.9
`49.2
`45.4
`48.8
`48.4
`50.0
`48.9
`
`25.9
`25.0
`26.7
`26.8
`
`N
`
`35
`56
`25
`25
`35
`35
`45
`40
`36
`106
`101
`
`20
`20
`40
`40
`
`Epidural blockade was performed in a standardised manner at the second
`lumbar interspace with the patient sitting up, as previously described (BROMAGE
`1962a, b). In the majority of cases, a syringe filled with air was used for the
`loss-of-resistance test, in order to avoid possible errors of dosage from injecting
`an inexact amount of diluent at the moment of piercing the ligamentum
`flavum .
`
`Measurements of Sensory Blockade
`The patients were tested for analgesia to pin prick within two minutes of
`injection, and the upper and lower limits of segmental analgesia were charted
`on graph paper every minute until the spread of analgesia was complete.
`Thereafter, analgesia was tested every 5-1 0 minutes. The following information
`was obtained from plotting such a diagram (Fig. 2).
`1. Latency of Initial Onset: This is the time taken for analgesia to make its
`first objective appearance, usually in the upper lumbar dermatomes.
`2. Latency of Complete Spread: The time taken for analgesia to spread to
`its farthest limits and to become established in all segments between these
`upper and lower limits.
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`59
`
`DORSAL
`
`v)
`
`LUMBAR
`
`a z
`h
`v)
`
`SACRAL
`
`i
`
`- B y \ ,
`5
`10
`
`,
`,
`, ,
`IS 20 25 3 0
`MINUTES
`FIG. 2.-Dermatome graph of onset and decay of epidural analgesia.
`A = Latency of initial onset.
`B = Latency of complete spread.
`
`3. Extent of Segmental Spread: In terms of the relationship between the dose
`of anaesthetic used and the number of dermatomes rendered analgesic. Else-
`where, it has been shown that the spread of epidural analgesia is dependent
`on (a) age, and (b) the mass of anaesthetic solute injected, rather than on volume
`or concentration alone (BROMAGE 1962a, b, 1963), and so in this paper, spread
`will be expressed as the mass of base required to block one spinal segment.
`For example, supposing an epidural injection of 20 ml of 2 yo lidocaine hydro-
`chloride produced analgesia of all segments up to T,. If we count the spinal
`segments up from S,, this makes a total of 20 segments (5 sacral, 5 lumbar,
`and 10 thoracic). 20 ml of 2% lidocaine hydrochloride contains:
`20 x 17.5 mg of lidocaine base.
`350
`Dose
`- _ -
`- - 17.5 mg base per segment.
`20
`Segments
`By plotting the dose requirements of many individual cases against age
`we can obtain a mean regression line for any particular solution, and so
`compare the spreading effects of different solutions.
`4. Duration of Action: Figures for duration of action are apt to be misleading
`unless the observer states precisely what is meant by “duration”. Sometimes,
`
`Thus,
`
`

`

`60
`
`PHILIP R. BROMAGE
`
`one or two dermatomes will remain anaesthetised long after analgesia has
`disappeared from the rest of the area of blockade; and yet duration of action
`in these residual segments is clearly of no practical importance, for the anaes-
`thetist wants to know how long he can reasonably expect clinical analgesia
`to persist in the main area of the surgical field and in the segments immediately
`around it. For this reason, duration of action has been taken as the interval
`from the time of complete spread of analgesia to the point when analgesia
`has receded two spinal dermatomes. This has been called duration to recession
`of two segments.
`
`Measurement of Motor Blockade
`The pattern of motor blockade is slower to develop and of shorter duration
`than sensory analgesia. Therefore, for purposes of comparison between patients
`it is important that observations of motor blockade should be made at a relatively
`long interval after the induction of epidural analgesia, but before the block
`has begun to recede. An interval of 3 0 4 minutes after induction was chosen
`as the most suitable period for recording and comparing motor paralysis, for
`this is the point at which motor block is most intense after a single epidural
`injection.
`
`Intensity of motor block
`(with sensory block to S,)
`
`I. Complete
`
`11. Almost complete
`
`111. Partial
`
`IV. None
`
`Unable to move
`feet or knees
`
`J ]
`
`Able to move
`feet only
`
`Just able to
`move knrcs
`
`Full flexion of
`knees and fert
`
`FIG. J.--Assessment of motor blockade (see text)
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`61
`
`Tests for motor paralysis were made in patients with segmental analgesia
`above the 9th thoracic dermatome, and degrees of motor blockade were
`classified simply in terms of ability to move the feet and legs as in Fig. 3. The
`categories of blockade, Complete, Almost Complete, Partial and Nil were
`given arbitrary scores of 100, 66, 33 and 0 per cent respectively, so that the
`average results from each test solution could be expressed as a percentage of
`the maximum possible score of 100.
`
`Total Dose Requirements in Prolonged Obstetrical Administration
`120 obstetrical patients were given continuous epidural blockade for pain
`relief during labour and vaginal delivery, using a technique that has been
`described previously (BROMACE 196 1 ) .
`Briefly, an epidural catheter was inserted at the second lumbar interspace
`when the cervix was between 3 4 cm dilated. Analgesia of the lower thoracic
`and upper lumbar segments was maintained by injecting small volumes of
`analgesic solution up the catheter at intervals of 90-120 minutes until delivery
`was imminent. Then, with the patient sitting up, sacral analgesia was induced
`by injecting a larger volume of the anaesthetic. In this series, the period of
`analgesic administration varied between 1 and 19 hours.
`The 2 % hydrochloride salts with 1 :200,000 adrenaline were used in 40
`patients (20 lidocaine and 20 prilocaine), and a further two groups of 40
`patients each received lidocaine and prilocaine base with adrenaline.
`In each case the total dose of analgesic agent administered during labour
`was plotted against the duration of blockade. Regression lines were drawn
`through the accumulated data points in order to compare the mean dose
`requirements of the four solutions.
`
`R E S U L T S
`
`Ladeny
`The latency of onset and complete spread for the various test solutions
`are shown in Table 2, and the mean latency times are shown graphically in
`Fig. 4.
`Adrenaline shortens the latency of 2 yo and 3 yo prilocaine hydrochloride
`in the same way that it hastens the onset of 2 yo and 3 yo lidocaine hydrochloride
`(BROMAGE et al. 1964). For example, the very slow spreading time of 2%
`plain prilocaine hydrochloride is shortened from 20.2 minutes to 17.3 minutes.
`Latency is dramatically shortened by the C0,-base solutions and spread
`is fastest with 1.75% lidocaine C0,-base plus adrenaline, being complete in
`a mean time of 10.7 minutes.
`
`

`

`62
`
`PHILIP R. BROMAGE
`
`Solution
`
`PH
`
`1
`
`N
`
`Complete Spread
`
`1 $!!$s)
`
`I
`
`S.D.
`
`N
`
`S.D.
`
`2.3
`
`2.6
`2.4
`
`1.7
`2.8
`
`2.4
`2.7
`
`2.2
`
`2.0
`
`1.7
`
`2.2
`
`Onset
`
`I
`
`Mean
`
`$ih;
`
`6.6
`
`6.48
`
`6.46
`6.31
`
`6.27
`6.30
`
`6.70
`6.48
`
`6.49
`
`6.49*
`
`35
`
`51
`25
`
`25
`35
`
`35
`45
`
`45
`
`36
`
`6.49* 106
`
`5.5
`, 5.5
`
`4.9
`8.0
`
`7.3
`7.7
`
`5.2
`
`4.9
`
`3.7
`
`plain lidocaine HCI.. ..
`2
`2 :G lidocaine HCI +
`adrenaline. .............
`3 yo plain lidocaine HCI.. ..
`3 yo lidocaine HCI +
`adrenaline. .............
`2 yo plain prilocaine HCI. . .
`2 yo prilocaine HCI +
`adrenaline. .............
`3 yo plain prilocaine HCI.. .
`3 yo prilocaine HCl +
`adrenaline. .............
`1.75 yo plain lidocaine
`C0,-base. ..............
`1.75 yo lidocaine GO,-base +
`adrenaline. .............
`1.71 Yo prilocaine GO,-base +
`adrenaline. .............
`6.50* 100
`13.2
`98
`1.0
`4.12
`* pH of freshly opened ampoule at 28°C before evolution of carbon dioxide.
`After equilibration with CO, at 35.6 mm Hg, pH rises to 7.30.
`
`1.17
`
`1.2
`1.43
`
`1.2
`1.58
`
`1.81
`1.77
`
`0.83
`
`1.03
`
`35
`
`56
`25
`
`25
`33
`
`33
`42
`
`42
`
`35
`
`0.89
`
`100
`
`18.1
`
`16.3
`15.3
`
`14.0
`20.2
`
`17.3
`17.0
`
`16.2
`
`11.6
`
`10.7
`
`0 5 ONSET
`I
`
`10
`
`0
`
`I = COMPLETE SPREAD
`IS
`20
`
`2s
`
`LlDOCAlNE
`
`PROPITOCAINE
`
`2% PLAIN
`
`1% t ADRENALINE
`
`3% PLAIN
`
`3% t ADRfNALINE
`
`1% PLAIN
`
`1% t ADRENALINf
`
`3% ?LAIN
`
`3% t ADRfNALINf
`
`175% PLAIN
`
`LIDoCAINE
`
`PROPITOCAINE ( 171% + ADRENALINf
`
`175% I ADRENALINE
`
`HYDROCHLORIDE
`
`C 0 2 - BASE
`
`FIG. 4.-Mean
`
`0
`
`I5
`10
`MINUTES
`latencies of onset and complete spread.
`
`5
`
`10
`
`2s
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`63
`
`Spread of Analgesia
`The spread of analgesia, expressed as the mass of base required per spinal
`segment was plotted against age in every case, and mean regression lines were
`drawn through the data points for each test solution. The results are shown
`in Fig. 5, and are similar to data published previously (BROMACE 1962a, by
`BROMAGE et al. 1964).
`
`’. ’.
`
`’\
`
`----- 3% Plain Propitomine HCI
`1
`.._._. -.. 2% [ ~~~~~&
`[ HCI
`. -
`1.71% Propilocoins Base 1
`
`1.757. Lidocaine Bare
`
`+
`
`?:renoline
`
`‘\\
`
`’*-
`
`I
`20
`
`1
`40
`
`I
`60
`
`I
`80
`
`FIG. 5.-Regression
`
`AGE
`lines of epidural dose requirements per spinal segment in the ages of
`20 to 80 years.
`
`The drug requirements of base per spinal segment are practically identical
`for 2 yo lidocaine and prilocaine hydrochloride with and without adrenaline,
`as well as for 3% prilocaine with adrenaline. However, 3% plain prilocaine
`hydrochloride requires much higher dosage in the younger age groups.
`The C0,-base solutions with adrenaline spread appreciably further, and
`require less mass of base per segment than the hydrochloride salts, the de-
`
`

`

`64
`
`PHILIP R. BROMAGE
`
`crease in dose requirements amounting to a reduction of 15yo at 20 years of
`age to 25% at 80 years.
`
`I n k m i 0 of Motor Blockade
`The various test solutions produced widely differing degrees of motor
`block, from little or none with plain 2% or 3% lidocaine hydrochloride to
`60% of maximum with 1.75% lidocaine C0,-base with adrenaline (see Fig. 6).
`
`HYDROCHLORIDE
`
`LlDOCAlNE
`
`PROPITOCAINE
`
`2% P L A I N
`
`1Y t A D R I N A L I N I
`
`37. P L A I N
`
`37. t A D R I N A L I N I
`
`17. P L A I N
`
`17. t A D 1 I N A L I N I
`
`IT. ?LAIN
`
`37.
`
`A D R l N A L l N t
`
`I
`
`I
`
`I
`
`I
`
`I
`
`t
`
`I
`
`I
`
`C0,- BASE
`
`LIDoCAINE
`
`175% P L A I N
`1757. * A D R I N A L I N I
`PROPITOCAINE (1717. t A D R I N A L I N I
`
`30
`10
`4 0
`PERCENT OF MAXIMUM BLOCKADE
`Frc;. 6.-Average degree of motor blockade of legs expressed as percentage of maximum.
`
`50
`
`b0
`
`0
`
`10
`
`The hydrochloride salt of prilocaine produced slightly more motor block
`than lidocaine hydrochloride. Addition of adrenaline 1 : 200,000 consistently
`improved the quality of motor blockade of all the plain solutions and its effect
`was more marked with lidocaine than with prilocaine. The most intense motor
`paralysis was produced by the C0,-bases with adrenaline, and these solutions
`showed a 6 0 4 5 % improvement over the results with the equivalent hydro-
`chloride salts.
`
`Duration of Blockade
`Duration, in terms of recession of two dermatomes, is summarised in Fig. 7.
`Plain lidocaine, in both hydrochloride and C0,-base forms, has a short
`action of about 45 minutes, whereas plain prilocaine hydrochloride lasts
`about 75-80 minutes.
`All the solutions have their action extended to about the same duration
`of 95-100 minutes when adrenaline 1 :200,000 is added.
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`65
`
`LlDOCAlNE
`
`I
`I PROPITOCAINE
`
`2% PLAIN
`
`2% t ADRENALINE
`
`13% t ADRENALINE
`
`I
`
`[ 1% PLAIN
`1% + ADlENALlNE
`
`3% PLAIN
`13% t ADRtNALlNl
`
`175% PLAIN
`
`LIDoCAINE
`
`PROPITOCAINE ( 171% + ADRENALINE
`
`175% t ADRENALINE
`
`HYDROCHLORIDC
`
`CO, - BASE
`
`60
`40
`DURATION : MINUTES
`FIG. 7.-Duration of analgesia, from time of complete spread to recession of two spinal
`dermatomes.
`
`80
`
`100
`
`10
`
`Dose Requirements in Prolonged Obstetrical Administration
`The tendency for epidural blockade to spread widely in pregnant women at
`term has been noted elsewhere (BROMAGE 1961, BROMAGE 1962a, b). This
`characteristic is even more pronounced when the C0,-base solutions are em-
`ployed. For example, during the first stage of labour, an initial dose of 3 ml
`of 1.75% C0,-base lidocaine at the second lumbar interspace is usually
`sufficient to provide analgesia from TI,, to L,, whereas 4 or 5 ml of an equivalent
`concentration of the hydrochloride salt is required for the same segmental
`distribution. Moreover, in this dosage, the C0,-base solutions produce a more
`marked sacral hypalgesia, which often deepens to full analgesia after two
`or three repeated injections over a period of three to five hours, so that by
`the time the mother is ready for delivery, little, if any, attention has to be
`paid to providing additional sacral blockade. With the hydrochloride salts,
`on the other hand, a final injection of 10-13 ml of the 2 % solution, given in
`the sitting position, is usually required before painless forceps extraction can
`be effected.
`Thus, the total dose requirements of the C0,-base solutions are considerably
`reduced below those of their hydrochloride counterparts. Fig. 8 shows the mean
`total dose of the two salts of lidocaine and prilocaine expressed as volume of
`solution and as mass of base required for continuous pain relief during labour.
`It can be seen that the total dose is reduced by 25-35% when the C0,-base
`solutions are used.
`
`

`

`66
`
`PHILIP R. BROMACE
`
`PROPITOCAINE
`
`ML
`Solrtion
`
`HOURS OF CONTINUOUS ANALGESIA
`FIG. 8.-Total dose requirements for continuous epidural analgesia during labour and
`delivery. Regression lines for 2 % hydrochloride and equivalent C0,-base salts of lidocaine
`and prilocaine.
`
`This saving is of value in protracted cases extending over 24 hours, when
`the total dosage may be large enough to give rise to cumulative toxicity and
`high concentrations in the maternal and foetal blood (BROMAGE and ROBSON
`1961).
`
`DISCUSSION
`
`The main clinical characteristics of lidocaine and prilocaine are apparent
`from the results of the hydrochloride salts, summarised in figures 4-8. Plain
`2 yo lidocaine hydrochloride has a slow onset and transient action, and produces
`little or no motor blockade. Prilocaine has an even slower latency, but produces
`more motor paresis, and the plain solutions last appreciably longer than plain
`lidocaine, although when adrenaline is added, both compounds have approxi-
`mately the same duration.
`The addition of adrenaline 1 :2OO,OOO produces a much more favourable
`block with both drugs, shortening latency, and increasing the degree of block-
`ade and the duration of analgesia (BROMAGE et al. 1964). This improvement
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`67
`
`in the quality of blockade is associated with a diminished uptake by the
`circulation, and lower concentrations of the drug in the venous blood (BROMAGE
`and ROBSON 1961).
`Contrary to previously accepted ideas, increasing the concentration of
`drug does not appear to improve the quality of epidural blockade appreciably,
`although latency may be shortened somewhat at certain concentrations
`(BROMAGE 1963, BROMAGE et al. 1964).
`The apparent superiority of 3% plain prilocaine over the 2% solution is
`offset by the large dose requirements of the former solution (see Fig. 5). The
`mean regression lines for the dose requirements of the other hydrochloride
`solutions are practically identical at any given age, but 3% plain prilocaine
`deviates from these, and a much larger mass of drug is required per dermatome
`in the younger age groups. The reason for this deviation is not immediately
`apparent, but its association with youth and its disappearance in old age
`suggests that it may be due to a more rapid uptake and metabolic destruction
`by non-nervous tissue.
`Thus, although prilocaine is less toxic than lidocaine, the 3 yo plain solution
`does not appear to offer any real advantage over the other test solutions and the
`clinical results with 2% plain prilocaine are almost as good as 3y0, if an
`adrenaline-free solution is required.
`The most effective blocks were provided by the C0,-base solutions. These
`produced a very rapid onset and spread of analgesia, and the quality of sensory
`and motor blockade was more intense than with any of the other solutions.
`Although the duration of blockade is not lengthened appreciably by these
`solutions, the tendency to spread over a wider number of segments reduces
`the total dose requirements below those of the hydrochloride solutions, and
`so the dangers of chronic or cumulative toxicity are less, especially during
`prolonged administration.
`The increased spreading tendencies and reduced dosage requirements of
`the C0,-base solutions were particularly noticeable in the obstetrical series,
`where sacral analgesia developed early, and where total dosage was reduced
`about 30% below that of the hydrochloride solutions. Although it can be
`argued that such an early sacral analgesia is theoretically undesirable in the
`first stage of labour (BROMAGE 1961), no undue delay of labour was observed
`in any of these cases.
`The marked effeciency of the C0,-base solutions is due in part to the regional
`intracellular acidosis that they produce from the rapid diffusion of COP
`Naturally, the possible hazards of such a regional hypercarbia must be con-
`sidered if it k to be applied to clinical anaesthesia, for there are theoretical
`dangers associated with the production of an area of low intracellular pH by
`high partial pressures of carbon dioxide.
`Now, each cell carries within itself the seeds of its own destruction in the
`form of lysosomes, and the lysosomal enzymes have a narrow optimal pH in
`
`

`

`68
`
`PHILIP R. BROMAGE
`
`the region of 5.0 (WEBS 1963), so that profound intracellular acidosis leads
`to activation of the autolytic enzymes and death of the cell.
`However, in spite of a high pCO,, the actual quantity of carbon dioxide
`present in the C0,-base solutions is small and each millilitre contains about
`0.1 mMole of C02, 0.035 mMole being in solution, plus 0.069 mMole in
`combination as bicarbonate. Thus, the total dose of CO, in an injection of
`20 ml of C0,-base will amount to only 2.0 mMole. The rapid diffusion of
`CO, ensures that this small quantity will be quickly dissipated through the
`tissues, and so it is most improbable that any group of cells will be exposed to
`a high concentration of CO, for long enough to depress intracellular pH to
`dangerous levels.
`Moreover, even direct application of carbon dioxide at one atmosphere to
`a non-myelinated axon has not produced a measured fall of pH below 6.0
`(CALJNELL 1958), and it seems most unlikely that nerves of the intact body,
`surrounded as they are by so many tissue barriers, will suffer such a severe
`acidosis from a comparable but transient partial pressure of COP
`Clinically, the C0,-base solutions appear to be safe and free of undesirable
`side effects. They have been employed in an additional 115 patients who, for
`a number of reasons, could not be categorised in this comparative series. Some
`of these patients were severely arteriosclerotic and some gravely ill from other
`causes. And so a total number of more than 400 patients have received epidural
`blocks with the C0,-base solutions and no untoward effects have been en-
`countered.
`The marked efficiency of the C0,-base solutions in epidural analgesia
`makes them superior in every way to their hydrochloride counterparts, and
`it would seem that they are worthy of wider clinical trial. The advantage to
`be gained is probably greatest in the case of prilocaine. This compound is less
`toxic than lidocaine, but the very slow latency of its hydrochloride solutions
`is an undesirable feature for epidural techniques in a busy operating theatre.
`On the other hand, the C0,-salt combines low toxicity with rapid onset and
`intense sensory and motor blockade.
`
`SUMMARY
`
`Lumbar epidural blockade has been used in a series of 659 patients to
`compare the analgesic properties of lidocaine and prilocaine.
`Solutions of both compounds were compared as hydrochloride salts in 2%
`and 3 % concentration with and without adrenaline 1 : 200,000. Solutions of
`base, made soluble by equilibration with carbon dioxide at a pC0, of 700
`mm Hg were also compared in concentrations of 1.75 yo for lidocaine and 1.7 1 %
`for prilocaine.
`
`

`

`LIDOCAINE AND PRILOCAINE IN EPIDURAL ANALGESIA
`
`69
`
`Comparisons were based on measurements of latency, spread of analgesia,
`intensity of motor blockade and duration of analgesia.
`The quality of blockade in all the test solutions was increased by the addition
`of 1 : 200,000 adrenaline. Prilocaine has a slow latency compared with lidocaine,
`but in plain solution its duration is longer than that of lidocaine.
`The 3 % hydrochloride solutions have no practical advantage over the
`2 % solutions for epidural blockade.
`Analgesia resulting from the C0,-base solutions is superior in every respect
`to the blockade produced by equivalent concentrations of the hydrochloride
`salts.
`
`McGil1:University and Royal Victoria Hospital, Montreal, Canada.
`
`R E F E R E N C E S
`
`ALBERT, A.: Ionization, pH and biological activity. Pharmacol. Rev. 1952, 4, 136.
`BROMAQE, P. R.: Continuous lumbar epidural analgesia for obstetrics. Canad. mcd. Ass. 3.
`1961,8!5, 1136.
`BROMAGE, P. R.: Spread of analgesic solutions in the epidural space and their site of action;
`a statistical study. Brit. 3. Anacsth. 1962 (a), 34, 161.
`BROMAQE, P. R. : Exaggerated spread of epidural analgesia in arteriosclerotic subjects.
`Brit. m d . 3. 1962 (b), 2, 1634.
`BROMAGE, P. R. : Regional Anaeshesia, Spinal Anaestesia. International Anesthesiology Clinics.
`Little Brown & Company, Boston, Mass. 1963, 1, 547.
`BROMAGE, P. R., M. F. BURFOOT, D. E. CROWELL and R. T. PEITIGREW: Quality of epidural
`blockade. I: Influence of physical factors. Brit. 3. Anacsth. 1964, 36, 342.
`BROMAQE, P. R., and J. G. ROBSON: Concentrations of lignocaine in the blood after intra-
`venous, intramuscular, epidural and endotracheal administration. Anaesthesia 1961,
`16, 461.
`CALDWELL, P. C.: Studies on the internal pH of large muscle and nerve fibres. 3. Physwl.
`1958, 142,22.
`HALPERN, B. N., and R. BINAQHI: Selective permeability of living membranes to carbonic
`acid. Nature 1959, 183, 1397.
`KRAHL, M. E., and G. H. A. CLOWES: Physiological effects of nitro- and halo-substituted
`phenols in relation to extracellular and intracellular hydrogen ion concentration. 11.
`3. cell. COW. Physiol. 1938, 11, 21-39.
`KRAHL, M. E., A. K. KLETCH, and G. H. A. CLOWES: Role of changes of extracellular
`and intracellular hydrogen ion concentration in action of local anaesthetic bases.
`3. Pharmacol. exp. Thcr. 1940, 68, 330.
`LOPOREN, N. : Studies on local anesthetics. Xylocaine, a new synthetic drug. Haeggstrom, Stock-
`holm, 1948, pp. 82 and 104.
`TRUANT, A. P., and P. R. BROMAGE: To be published.
`WEIS, L.: The structure and function of the membranes and surfaces of cells. Biochem. Soc. Symp.
`1963, No. 22, p. 45, Cambridge University Press, Cambridge, England.
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket